BIG 1-98: Letrozole vs tamoxifen

Share :
Published: 11 Mar 2009
Views: 13617
Dr Alan Coates - School of Public Health, University of Sydney
BIG 1-98: A randomized double-blind phase III study evaluating letrozole and tamoxifen given in sequence as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer. Alan Coates, M.D., clinical professor in the School of Public Health at the University of Sydney in Australia, speaking at the 2008 San Antonio Breast Cancer Symposium